Scientists test new drug formulation in early safety study
Knowledge-focused
Ongoing
This early study aims to understand how the body absorbs a new granule form of the drug Aramchol compared to its existing tablet form. Sixteen healthy volunteers will take single doses of each form on different days to measure drug levels in their blood. The goal is to see if the…
Phase: PHASE1 • Sponsor: Galmed Pharmaceuticals Ltd • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC